MARRONE BIO INNOVATIONS, INC. (NASDAQ:MBII) Files An 8-K Results of Operations and Financial Condition
Item2.02. Results of Operations and Financial Condition.
On May11, 2017, Marrone Bio Innovations, Inc. (the Company)
issued a press release announcing and will hold a press
conference regarding its results of operations for the fiscal
quarter ended March31, 2017. A copy of the press release is
furnished as Exhibit 99.1 to this report.
The information furnished to this Item2.02, including Exhibit
99.1, shall not be deemed filed for purposes of Section18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act),
or otherwise subject to the liabilities under that section and
shall not be deemed to be incorporated by reference into any
filing of the Company under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set
forth by specific reference in such filing.
Item9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
Description |
|
| 99.1 |
Press release issued on May 11, 2017 by Marrone Bio Innovations, Inc. |
About MARRONE BIO INNOVATIONS, INC. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601. MARRONE BIO INNOVATIONS, INC. (NASDAQ:MBII) Recent Trading Information
MARRONE BIO INNOVATIONS, INC. (NASDAQ:MBII) closed its last trading session up +0.08 at 1.50 with 132,325 shares trading hands.